Sanofi’s protein-based vaccine Nuvaxovid has conquered Moderna’s next-generation messenger RNA shot mNexspike in a ...

In a blow to Bayer, a U.S. federal judge in Manhattan has said he will not block Johnson & Johnson’s survival claims on a key ...

Biovac has secured a $108.3 million financing package that will allow the South African pharma company to build the continent ...

Genentech has launched the “Life Doesn’t Wait” campaign to mark World Hemophilia Day, dialing up its focus on patient stories ...

AbbVie is running a new psoriasis campaign based on feedback from real patients about how the condition affects their daily ...

Neurogene is looking to make the leap from a clinical biotech to a commercial biopharma with its lead gene therapy and has ...

Biogen and Minor League Baseball’s Durham Bulls are joining forces to celebrate “America 250” in the Triangle Community.  | ...

Theramex has opted out of the U.K.’s self-regulatory program for pharma ma | Theramex has opted out of the U.K.’s ...

AI heavyweight Anthropic has appointed Novartis CEO Vas Narasimhan to its board of directors as the link between the ...

Astellas will close a stem cell therapy site. GSK is pushing a Hansoh Pharma-partnered ADC into multiple phase 3 trials. | ...

Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva ...

As biosimilar competition to Johnson & Johnson’s Stelara continues to chew off sales, the much-anticipated launch of the ...